The NYU Center for Particulate Matter Health Research is conducting studies to identify tiny particles in polluted air that contribute to respiratory ailments, including asthma and chronic obstructive pulmonary disease. The center aims to establish specific chemical species responsible for mortality and morbidity associated with exposure.
The NYU Medical Center is launching a large-scale study to determine the effectiveness of combining CT scans with gene markers in detecting early-stage lung cancer in women. The study aims to identify reliable screening tools for women at high risk of developing this deadly disease.
The conference will focus on ibogaine's mechanism of action and clinical, cultural, and political issues surrounding its use. Leading experts in neuroscience, ethnography, and sociology will present on the compound's effects and potential applications.
Researchers identified a novel human gene, BRI, that causes an unusual form of hereditary dementia. The discovery provides new insights into the disease and may lead to the development of a blood test to detect the mutation.
A combination of radiation and chemotherapy treatment significantly increased overall survival in esophageal cancer patients, with 22% surviving at least eight years after treatment. The study found that this combined therapy was associated with longer survival compared to radiation therapy alone.
Researchers discovered that lysozyme, a protein abundant in tears, is also present in the urine of pregnant women and acts as a potent anti-HIV agent. Additionally, ribonucleases were identified in the urine, breaking apart viral RNA and potentially inhibiting HIV replication.
Researchers discover the structure of a key compound enabling the bacterium's deadly mechanism and create molecules that block its effects in mice. The study provides a novel way to combat Staphylococcus aureus infections without killing the bacteria, potentially addressing antibiotic resistance.
Researchers at NYU School of Medicine have developed a method to measure anatomical changes in the entorhinal cortex, a key memory center in the brain. This technique uses MRI scans and reveals that patients with very mild Alzheimer's disease show significant shrinkage in this area compared to healthy volunteers.
A new study by NYU Langone Health researcher Susan Harlap found that breast cancer surgery timing has no impact on survival rates since the mid-1980s. Changes in medical practice, including improved anesthesia and post-operative care, may have contributed to this shift.
Scientists have created a synthetic peptide that blocks the formation of amyloid plaques in the brain, destroying existing plaques and preventing nerve cell death. This breakthrough may lead to a new therapy for Alzheimer's disease and other diseases caused by defective protein folding.